Excerpt: Alpha DaRT is Alpha Tau's alpha-emitting radiation therapy in testing across solid tumors — the head-and-neck readout is the near-term catalyst, while the balance sheet and dilution risk set the clock on how many shots the company gets. The hub lays out the pipeline (GBM, pancreatic, recurrent SCC), the FDA/clinical catalysts, cash runway and the main risks, updated over time.
Full write-up (free, no signup): https://www.merlintrader.com/alpha-tau-stock-hub/
Not financial advice — just research.